Sanara Medtech Stock Target Price and Analyst Consensus
| SMTI Stock | USD 36.84 0.53 1.46% |
The current analyst and expert consensus on Sanara Medtech is Strong Buy, with only one strong buy opinion. The current projected Sanara Medtech target price consensus is 47.00 with 2 analyst opinions. Check out Macroaxis Advice on Sanara Medtech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.The most common way Sanara Medtech analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Sanara Medtech executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Sanara Medtech. We encourage you to use your own analysis of Sanara Medtech to validate this buy or sell advice. Sanara Medtech buy-or-sell recommendation module provides average expert sentiment on the projected Sanara Medtech target price to derive its highest and lowest estimates based on projected price volatility of 2.9135.
Lowest Forecast 42.77 | Highest Forecast 52.17 | Target Price 47 |
Sanara |
It's important to approach Sanara Medtech's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Sanara Medtech Target Price Consensus
Sanara target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Sanara Medtech's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Strong Buy |
Most Sanara analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Sanara stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Sanara Medtech, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSanara Medtech Target Price Projection
Sanara Medtech's current and average target prices are 36.84 and 47.00, respectively. The current price of Sanara Medtech is the price at which Sanara Medtech is currently trading. On the other hand, Sanara Medtech's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Sanara Medtech Market Quote on 30th of January 2025
Target Price
Analyst Consensus On Sanara Medtech Target Price
Sanara Medtech Analyst Ratings
Sanara Medtech's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Sanara Medtech stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Sanara Medtech's financials, market performance, and future outlook by experienced professionals. Sanara Medtech's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Sanara Medtech price targets
Sanara Medtech's stock target price is an estimate of its future price, usually made by analysts. Using Sanara Medtech's target price to determine if it is a suitable investment can be done through the following steps:- Look at Sanara Medtech's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Sanara Medtech's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Sanara Medtech Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Sanara Medtech is a key component of Sanara Medtech valuation and have some predictive power on the future returns of a Sanara Medtech.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sanara Medtech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Automobiles and Trucks Invested over 300 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Impulse Invested over 100 shares | |
 | Social Domain Invested few shares | |
 | Banking Invested over 30 shares | |
 | FinTech Invested over 60 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Driverless Cars Invested over 300 shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Investor Favorites Invested over 300 shares | |
 | Manufacturing Invested over 30 shares | |
 | Momentum Invested few shares |
Check out Macroaxis Advice on Sanara Medtech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Sanara Stock please use our How to Invest in Sanara Medtech guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.